MedTrace Logo

Selpercatinib and Body Composition

NCT07543887 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2026-04-22

No results posted yet for this study

Summary

investigation of body composition

Conditions

Interventions

OTHER

observation in patient under treatment

observation in patient under treatment

DRUG

Selpercatinib

observational study of patients under selpercatinib

Sponsors & Collaborators

  • University of Pisa

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-12
Primary Completion
2026-04-04
Completion
2026-04-04
FDA Drug
Yes

Countries

  • Italy

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07543887 on ClinicalTrials.gov